SCHEMBL7808342

SCHEMBL7808342

O=C1c2ccccc2C(=O)c2sc(-c3ccc(Cl)o3)nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 8/20 0.55
▸ TDO2 P48775 5/20 0.55
▸ ADORA2A P29274 1/20 0.50
▸ ADORA1 P30542 1/20 0.50
▸ PTGS1 P23219 3/20 0.38
▸ USP1 O94782 2/20 0.35
▸ USP19 O94966 2/20 0.35
▸ WDR48 Q8TAF3 1/20 0.35
▸ PTGS2 P35354 4/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ DNMT1 P26358 1/20 0.33
▸ DNMT3L Q9UJW3 1/20 0.33
▸ DNMT3A Q9Y6K1 1/20 0.33
▸ CTRC Q99895 1/20 0.33
▸ UCHL3 P15374 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813124 0.83 IDO1 (0.55) IDO1TDO2USP1USP19WDR48
SCHEMBL7811891 0.83 IDO1 (0.55) IDO1TDO2ADORA2AADORA1USP1
SCHEMBL7814769 0.83 IDO1 (0.55) IDO1TDO2ADORA2AADORA1USP1
SCHEMBL7812948 0.81 IDO1 (0.52) IDO1TDO2NPC1ALDH1A1MAPT
SCHEMBL7811413 0.79 IDO1 (0.50) IDO1TDO2NPC1RAB9A
SCHEMBL7816639 0.77 IDO1 (0.57) IDO1TDO2ADORA2AADORA1ALDH1A1
SCHEMBL7805846 0.77 IDO1 (0.48) IDO1TDO2NPC1ALDH1A1MAPT
SCHEMBL7818266 0.77 IDO1 (0.55) IDO1TDO2USP1USP19WDR48
SCHEMBL7807731 0.76 IDO1 (0.52) IDO1TDO2USP1USP19WDR48
SCHEMBL7811377 0.76 IDO1 (0.52) IDO1TDO2USP1USP19WDR48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 — — US disclosed
Send feedback